Clinical trial
A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight…
NCT00483171 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00483171 |
|---|---|
| Title | A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients |
| Official title | A 14-Month, Randomized, Double-Blind,Placebo-Controlled Phase 3 Study To Evaluate The Long-Term Efficacy And Safety of CP-945,598 In Prevention Of Weight Regain In Obese Subjects |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Behavioral, Drug |
| Interventions | CP-945, 598, Non-pharmacological weight loss program (NPP), Low Calorie Diet |
| Enrollment | 699 |
| Start date | Jan 1, 2008 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Jun 6, 2007 |
| Last update posted | Nov 7, 2012 |
| Countries | Australia, Denmark, Netherlands, South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: